Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1533 (LINC01533) is a human long intergenic non-coding RNA (lincRNA) gene. LincRNAs are a subclass of long non-coding RNAs that are longer than 200 nucleotides and do not overlap annotated protein-coding genes[1][3][7]. These molecules are actively transcribed, typically by RNA polymerase II, and are involved in a variety of biological processes, primarily acting to fine-tune gene expression, modulate chromatin states, and participate in transcriptional and post-transcriptional regulation[3][7]. Some lincRNAs have been linked to tissue-specific gene regulation and disease processes such as cancer; however, the specific biological and clinical functions of LINC01533 remain poorly characterized. No drugs or therapeutics are currently known to target this RNA directly, and there are no established indications for its use as a clinical biomarker or therapeutic target[1]. LINC01533 is known by several aliases, including CTC-360P9.3 and LOC105376899[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1533 (LINC01533).